Latest Beta amyloid Stories
Researchers at the Department of Psychiatry and Psychotherapy of the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently gained new insights into treating Alzheimer's disease.
Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enroll more than 1,500 patients in 15 countries INDIANAPOLIS, Dec.
-Discovery of Novel Investigational Drug Candidates that Interact with sigma-2/PGRMC1 Receptor Offer Potential to Stop and Reverse Memory Loss in Alzheimer's Patients - PITTSBURGH,
Animal study reveals potential brain-health benefits of a walnut-enriched diet FOLSOM, Calif., Oct.
New Study Shows Link between Plaques and Tangles/Could Open Door to Therapeutic Target Boston (PRWEB) October 13, 2014 In what is being hailed by scientists
Neurotrope's Collaborator BRNI, Publishes Article in the Journal of Alzheimer's Disease describing correlation of PKCe levels and degree of disease PLANTATION, Fla., Aug.
A team of scientists, led by Western University of Health Sciences Professor Doug Ethell, PhD, has developed a blood test for Alzheimer’s disease risk that may lead to earlier detection and
MELBOURNE, Australia, July 17, 2014 /PRNewswire/ -- Prana Biotechnology (NASDAQ: PRAN; ASX: PBT) has today provided an update on its clinical development program for Alzheimer's disease. Professor
- A trick or prank.